Applied Biosystems/MDS Analytical Technologies Launches New Mass Spectrometry Tools to Advance Public Health and Safety.Cliquid 3.0 Software and mTRAQ Reagents to Enhance Contaminant contaminant /con·tam·i·nant/ (kon-tam´in-int) something that causes contamination. contaminant something that causes contamination. Testing, Forensic Drug Screening forensic drug screening Lab medicine A format for drug screening which requires specific specimen handling protocols from the time of collection to the point of analysis and final reporting. See Drug screening. Cf Therapeutic drug monitoring. and Protein Biomarker Research Applications CARLSBAD, Calif. -- Applied Biosystems Applied Biosystems, Inc. (formerly NASDAQ: ABIO) is the original name of a pioneer biotechnology company founded in 1981 in Foster City, California, among the Silicon Valley cities of the southern San Francisco Bay Area. , a division of Life Technologies Corporation (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :LIFE), and its mass spectrometry mass spectrometry or mass spectroscopy Analytic technique by which chemical substances are identified by sorting gaseous ions by mass using electric and magnetic fields. joint-venture partner, MDS MDS, n See temporomandibular pain-dysfunction syndrome. MDS 1 Maternal deprivation syndrome, see there 2 Myelodysplastic syndrome, see there Analytical Technologies, a business unit of MDS Inc. (TSX TSX Toronto Stock Exchange (TSE before April, 2002) TSX Transfer from Stack Pointer to Index TSX True Space Extension :MDS) (NYSE NYSE See: New York Stock Exchange :MDZ MDZ Mendez MDZ Moskauer Deutsche Zeitung (Moscow German newspaper) MDZ Maritime Defense Zone MDZ Musik Der Zukunft (music label & community) MDZ Mendoza, Mendoza, Argentina - El Plumerillo ), today announced the commercial availability of new mass spectrometry tools to help laboratories in a variety of industries advance their efforts to improve public health and safety. The Cliquid([R]) 3.0 Software application and mTRAQ([R]) triplex triplex /tri·plex/ (tri´pleks) triple or threefold. triplex triple or threefold. reagents are designed to enhance food and water contaminant testing, forensic drug screening and protein biomarker research. Cliquid([R]) 3.0 Software is an automated software application for contaminant testing and forensic analysis. It enables scientists to identify unknown compounds, expanding the scope of Cliquid software to identify the greatest number of compounds and driving the life-science industry's most comprehensive solution for food and water contaminant testing as well as forensic drug screening for emerging variations of illicit drugs. mTRAQ([R]) triplex reagents are a set of chemical reagents that label proteins in complex samples for targeted quantitation. They make biomarker verification more accurate, doubling the throughput of analysis, which is expected to accelerate the use of increasing numbers of biomarkers in clinical settings. These tools, which are optimized for Applied Biosystems/MDS Analytical Technologies mass spectrometers, including the AB SCIEX 5500 Systems and AB SCIEX TOF/TOF 5800 System, enable scientists to increase their ability to use mass spectrometry systems to identify and quantify compounds or contaminants. For example, food testing laboratories can detect unknown contaminants that may be present in the food supply, while forensic laboratories may be able to identify new designer street drugs in forensic investigations. In the proteomics field, researchers can more rapidly verify and validate biomarkers to support their potential use in clinical settings, including the emergence of personalized medicine  The external links in this article or section may require cleanup to comply with Wikipedia's content policies. .
Laura Lauman, President of Life Technologies' Mass Spectrometry Systems Division "Scientists in a variety of industries are continuing to employ the power of mass spectrometry to advance their efforts in improving public health and safety. Applied Biosystems/MDS Analytical Technologies continues to support these scientists by providing them with innovative technologies that deliver complete workflow solutions, including industry-leading platforms, software and applications." Andy Boorn, President of MDS Analytical Technologies "Applied Biosystems/MDS Analytical Technologies continues to drive new standards for mass spectrometry-based software applications to maximize the innovation of our platforms. We are evolving our technologies to provide the highest-performing tools, responding to customer requirements to expand the capabilities of laboratories." Additional Resources Food Testing Solutions Biomarker Solutions About Applied Biosystems Products Applied Biosystems is a global leader in providing innovative instrument systems to accelerate academic and clinical research, drug discovery and development, pathogen detection and forensic DNA analysis DNA analysis Any technique used to analyze genes and DNA. See Chromosome walking, DNA fingerprinting, Footprinting, In situ hybridization, Jeffries' probe, Jumping libraries, PCR, RFLP analysis, Southern blot hybridization. . Applied Biosystems, along with Invitrogen - a leading provider of platform independent, essential life science technologies for disease and drug research, bioproduction and diagnostics - is part of Life Technologies. Applied Biosystems and Invitrogen products are used in nearly every major laboratory in the world. For more information, please visit: www.appliedbiosystems.com and www.invitrogen.com. About Life Technologies Life Technologies Corporation (NASDAQ:LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics See computer forensics. . Life Technologies had sales of more than $3 billion in 2008, employs approximately 9,500 people, has a presence in more than 100 countries, and possesses a rapidly growing intellectual property estate of approximately 3,600 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc. For more information on how we are making a difference please visit our website: www.lifetechnologies.com. About MDS Analytical Technologies MDS Analytical Technologies, a business unit of MDS Inc. (TSX:MDS) (NYSE:MDZ), is focused on the research, design, manufacture and marketing of state-of-the-art tools for mass-spectrometry, drug discovery and bioresearch bi·o·re·search n. Research in the biological sciences. . MDS Analytical Technologies' products are designed to help accelerate the complex process of discovering and developing new drug compounds, and are sold to research scientists around the world. The mass-spectrometer product lines are also sold globally through joint ventures with two of the world's leading analytical instrumentation and life-sciences companies, Life Technologies Corporation and PerkinElmer, Inc. Find out more at www.mdssciex.com or www.moleculardevices.com. Life Technologies Safe Harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. Statement This press release includes forward-looking statements about Life Technologies' anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense future tense n. A verb tense expressing future time. Noun 1. future tense - a verb tense that expresses actions or states in the future future or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances. Copyright 2009. Life Technologies Corporation. All rights reserved. Cliquid and mTRAQ are registered trademarks of Applied Biosystems/MDS Analytical Technologies, a joint venture between Applied Biosystems LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control and MDS Inc. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion